TIDMHIK
RNS Number : 2787S
Hikma Pharmaceuticals Plc
15 March 2021
Hikma Pharmaceuticals PLC - EIP B Vesting
LONDON, 15 March 2021: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces
that the following Persons Discharging Managerial Responsibility
("PDMR") have received shares as a result of the vesting of their
conditional share awards which were granted on 12 March 2019 under
the 2014 Executive Incentive Plan ("EIP") Element B.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
12 March 2021 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 61,666
d) Aggregated information
* Volume
61,666
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 12 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Siggi Olafsson
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Sigurdur Olafsson
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
12 March 2021 under the EIP Element B. Shares
were sold to cover tax and the remainder were
retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 35,513
Price(s): GBP22.057
Volume(s): 31,794
d) Aggregated information
* Volume
67,307
GBP22.057
* Price GBP701,280.26
* Total
e) Date of the transaction 12 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
12 March 2021 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 42,572
d) Aggregated information
* Volume
42,572
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 12 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Riad Mishlawi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Riad Mishlawi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
12 March 2021 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 32,027
d) Aggregated information
* Volume
32,027
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 12 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Majda Labadi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Majda Labadi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
12 March 2021 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 17,091
d) Aggregated information
* Volume
17,091
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 12 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Bassam Kanaan
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
12 March 2021 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 27,193
d) Aggregated information
* Volume
27,193
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 12 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
12 March 2021 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 25,089
d) Aggregated information
* Volume
25,089
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 12 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Brian Hoffmann
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Brian Hoffmann
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
12 March 2021 under the EIP Element B. Shares
were sold to cover tax and the remainder were
retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 8,435
Price(s): GBP22.057
Volume(s): 7,552
d) Aggregated information
* Volume
15,987
GBP22.057
* Price GBP166,574.46
* Total
e) Date of the transaction 12 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Susan Ringdal
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Susan Ringdal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
12 March 2021 under the EIP Element B. Shares
were sold to cover tax and the remainder were
retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 7,626
Price(s): GBP22.057
Volume(s): 6,828
d) Aggregated information
* Volume
14,454
GBP22.057
* Price GBP150,605.20
* Total
e) Date of the transaction 12 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Henriette Nielsen
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Henriette Nielsen
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
12 March 2021 under the EIP Element B. Shares
were sold to cover tax and the remainder were
retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 4,627
Price(s): GBP22.057
Volume(s): 5,275
d) Aggregated information
* Volume
9,902
GBP22.057
* Price GBP116,350.68
* Total
e) Date of the transaction 12 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
15 March 2021
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBBGDXSDBDGBU
(END) Dow Jones Newswires
March 15, 2021 07:24 ET (11:24 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Mar 2023 to Mar 2024